Hatch-Waxman litigation: How legal finance supports brands and generics even when monetary damages aren’t at stake

Pharmaceutical and life sciences businesses of all types, including smaller or cost-constrained corporates and those with larger budgets, are increasingly familiar with legal finance. It is an essential tool in high-value patent infringement cases in which plain…